LEAH YOUNG: Open Payments
NPI 1194290551 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 50 payments from 14 companies in 2025. Trend: 2023 $271 · 2024 $823 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $159 |
| Janssen Pharmaceuticals, Inc | 6 | $134 |
| Neurocrine BioSciences, Inc. | 5 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Biogen, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $32 |
Products named: VRAYLAR, INGREZZA, REXULTI, SPRAVATO, CAPLYTA, TRINTELLIX, INVEGA SUSTENNA, ZURZUVAE.
Industry payments across UT — which companies pay providers there.
